<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Titania-coated gold nanorods as an effective carrier for gambogic acid   - RSC Advances (RSC Publishing) DOI:10.1039/C7RA08560E</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2017/ra/c7ra08560e"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":334,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Hong-Ye Wan"/><meta name="DC.Creator" content="Jian-Li Chen"/><meta name="DC.Creator" content="Xiao-Yan Yu"/><meta name="DC.Creator" content="Xiao-Ming Zhu"/><meta name="DC.title" content="Titania-coated gold nanorods as an effective carrier for gambogic acid  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2017/10/25"/><meta name="DC.Identifier" scheme="doi" content="10.1039/C7RA08560E"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Titania-coated gold nanorods as an effective carrier for gambogic acid  "/><meta name="citation_author" content="Hong-Ye Wan"/><meta name="citation_author" content="Jian-Li Chen"/><meta name="citation_author" content="Xiao-Yan Yu"/><meta name="citation_author" content="Xiao-Ming Zhu"/><meta name="citation_online_date" content="2017/10/25"/><meta name="citation_date" content="2017"/><meta name="citation_journal_title" content="RSC Advances"/><meta name="citation_volume" content="7"/><meta name="citation_issue" content="78"/><meta name="citation_firstpage" content="49518"/><meta name="citation_lastpage" content="49525"/><meta name="citation_doi" content="10.1039/C7RA08560E"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2017/ra/c7ra08560e"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2017/ra/c7ra08560e"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2017/ra/c7ra08560e"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2017/ra/c7ra08560e">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:c7ra08832a)" href="/en/content/articlehtml/2017/ra/c7ra08832a" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:c7ra09023d)" href="/en/content/articlehtml/2017/ra/c7ra09023d" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div><br/><span class="oa"><img src="/content/newimages/open_access_blue.png" alt=""/> Open Access Article<br/><img src="/content/newimages/CCBY.svg" alt=""/>
This Open Access Article is licensed under a <br/><a rel="license" href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution 3.0 Unported Licence</a></span></div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/C7RA08560E">10.1039/C7RA08560E</a>
(Paper)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2046-2069/2011">RSC Adv.</a></span>, 2017, <strong>7</strong>, 49518-49525</div><h1 id="sect223"><span class="title_heading">Titania-coated gold nanorods as an effective carrier for gambogic acid<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
<span class="bold">Hong-Ye Wan</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Hong-Ye Wan (orcid.org/0000-0002-0737-1141) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-0737-1141"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>, 
<span class="bold">Jian-Li Chen</span>, 
<span class="bold">Xiao-Yan Yu</span><span class="bold"> and </span>
<span class="bold">Xiao-Ming Zhu</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Xiao-Ming Zhu (orcid.org/0000-0001-8545-1211) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0001-8545-1211"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*
<br/><span class="italic">State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau, China. E-mail: <a href="mailto:xmzhu@must.edu.mo">xmzhu@must.edu.mo</a></span>
</p><div id="art-admin"><span class="italic bold">Received 
3rd August 2017
</span><span class="bold italic">, Accepted 13th October 2017</span></div><p class="bold italic">First published on 25th October 2017</p><hr/><div class="abstract"><h2>Abstract</h2><p>Gambogic acid (GA), a natural product, exhibits potent anticancer effects. Unfortunately, further clinical application of this drug is limited by its poor solubility in aqueous solutions. In the present study, titanium dioxide (TiO<small><sub>2</sub></small>)-coated gold nanorod (GNR/TiO<small><sub>2</sub></small>) nanostructures were used as a carrier for GA. The GNR/TiO<small><sub>2</sub></small> nanostructure-based delivery was found to provide a stable aqueous dispersion of GA. Compared with the free form, enhanced intracellular GA delivery was achieved by using the GNR/TiO<small><sub>2</sub></small> nanostructures. An <span class="italic">in vitro</span> cytotoxicity study indicated that the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures were much more effective in inhibiting the proliferation of human glioblastoma U-87 MG cells than free GA, particularly at lower working concentrations. Furthermore, the GNR/TiO<small><sub>2</sub></small> nanostructures displayed a high photothermal conversion efficiency, and irradiation at a low dose (5.3 W cm<small><sup>−2</sup></small>, 2 min) with an 808 nm laser also synergistically enhanced the anticancer effect of the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures. Therefore, our results suggest that GNR/TiO<small><sub>2</sub></small> nanostructure-based drug delivery is a promising method to improve the therapeutic efficacy of GA.</p></div><hr/>
<h2 id="sect275"><span class="a_heading">1. Introduction</span></h2>
<span>Gambogic acid (GA) is a xanthonoid compound isolated from the resin of <span class="italic">Garcinia hanburyi</span>. It has been identified as a potent anticancer agent that inhibits the proliferation of a variety of cancer cells <span class="italic">in vitro</span> and <span class="italic">in vivo</span>.<a title="Select to navigate to reference" href="#cit1"><sup><span class="sup_ref">1–5</span></sup></a> GA has been approved by the Chinese Food and Drug Administration (CFDA) for a phase II clinical trial for treating lung cancer. Despite this great potential, a major problem encountered with GA is its poor water solubility (&lt;1 μg mL<small><sup>−1</sup></small>), which limits its clinical application. This is because direct intravenous administration of hydrophobic drugs usually causes aggregation, which may block blood capillaries, or lead to an insufficient drug dose at the lesion site.<a title="Select to navigate to references" href="#cit6"><sup><span class="sup_ref">6</span></sup></a> Therefore, a critical challenge for furthering the application of GA is its pharmaceutical formulation.</span>
<p class="otherpara">Nanotechnology holds great promise for the delivery of anticancer drugs, especially for hydrophobic drugs. Encapsulation of hydrophobic drugs in nanomaterials can increase the solubility of these drugs. The passive and active targeting effects of the nanocarriers also allow for preferential accumulation of drug at the tumor site.<a title="Select to navigate to references" href="#cit7"><sup><span class="sup_ref">7</span></sup></a> Moreover, the intracellular drug concentration is often higher when nanoparticles are used, as P-glycoprotein efflux pumps frequently do not recognize nanoparticles.<a title="Select to navigate to reference" href="#cit8"><sup><span class="sup_ref">8,9</span></sup></a> Abraxane™ (Abraxis, Celgene), which is an albumin-bounded nano-formulation of paclitaxel, has been approved by the U.S. FDA for treating metastatic breast cancer.<a title="Select to navigate to reference" href="#cit10"><sup><span class="sup_ref">10,11</span></sup></a> Recently, Cremophor EL,<a title="Select to navigate to references" href="#cit12"><sup><span class="sup_ref">12</span></sup></a> chitosan,<a title="Select to navigate to references" href="#cit13"><sup><span class="sup_ref">13</span></sup></a> polyethylene glycol (PEG),<a title="Select to navigate to references" href="#cit14"><sup><span class="sup_ref">14</span></sup></a> lipoproteins,<a title="Select to navigate to references" href="#cit15"><sup><span class="sup_ref">15</span></sup></a> and dendrimers,<a title="Select to navigate to references" href="#cit12"><sup><span class="sup_ref">12</span></sup></a> have been used as drug-delivery vehicles for GA. However, these drug-delivery systems still have some drawbacks. For example, Cremophor EL has several side effects including cardiotoxicity, nephrotoxicity, neurotoxicity, and hypersensitivity reactions.<a title="Select to navigate to references" href="#cit16"><sup><span class="sup_ref">16</span></sup></a> Therefore, developing novel delivery systems for GA is essential.</p>
<p class="otherpara">Recently, gold nanostructures have attracted much attention for their applications in cancer diagnosis and therapy.<a title="Select to navigate to reference" href="#cit17"><sup><span class="sup_ref">17–19</span></sup></a> Among various gold nanostructures, gold nanorods (GNRs) are widely studied due to their unique plasmonic properties. Their localized surface plasmon resonance (LSPR) can be easily tuned to the near-infrared (NIR) region, and this property makes GNRs a candidate agent for <span class="italic">in vivo</span> imaging and therapy,<a title="Select to navigate to reference" href="#cit19"><sup><span class="sup_ref">19,20</span></sup></a> as light in the NIR region can penetrate deeply into tissues.<a title="Select to navigate to references" href="#cit21"><sup><span class="sup_ref">21</span></sup></a> When irradiated with an NIR laser, GNRs are able to convert light energy into heat, which induces cancer cell death. GNRs show great potential for cancer photothermal therapy. When GNRs serve as anticancer drug carriers, the heat can trigger anticancer drug release or enhance the cytotoxicity.<a title="Select to navigate to reference" href="#cit22"><sup><span class="sup_ref">22–24</span></sup></a></p>
<p class="otherpara">Titanium dioxide (TiO<small><sub>2</sub></small>) nanoparticles have many important applications in solar cells<a title="Select to navigate to references" href="#cit25"><sup><span class="sup_ref">25</span></sup></a> and photocatalysis.<a title="Select to navigate to references" href="#cit26"><sup><span class="sup_ref">26</span></sup></a> TiO<small><sub>2</sub></small> shows a high binding affinity to carboxylic acids, and the types of binding exhibited by carboxylic groups on TiO<small><sub>2</sub></small> include simple adsorption (electrostatic attraction and hydrogen bonding) and chemical adsorption (ester linkage, bridging, and chelating).<a title="Select to navigate to references" href="#cit27"><sup><span class="sup_ref">27</span></sup></a> In this study, TiO<small><sub>2</sub></small>-coated GNR (GNR/TiO<small><sub>2</sub></small>) nanostructures were firstly reported as a drug carrier for GA, as the GA molecule has a carboxylic acid group. The anticancer effect of GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures was compared with that of the free drug. In addition, the synergistic anticancer effect of GNR/TiO<small><sub>2</sub></small> nanostructure-based photothermal therapy and GA was investigated.</p>

<h2 id="sect312"><span class="a_heading">2. Experimental</span></h2>
<h3 id="sect315"><span class="b_heading">2.1. Preparation of the GNR nanostructures</span></h3>
<span>A cetyltrimethylammonium bromide (CTAB)-capped GNR (GNR/CTAB) sample was prepared through a seed-mediated growth method.<a title="Select to navigate to references" href="#cit28"><sup><span class="sup_ref">28</span></sup></a> Briefly, the seed solution was made by adding a freshly prepared, ice-cold NaBH<small><sub>4</sub></small> solution (0.01 M, 0.6 mL) into a mixture of HAuCl<small><sub>4</sub></small> (0.01 M, 0.25 mL) and CTAB (0.1 M, 9.75 mL). The resultant seed solution was kept at room temperature for 2 h before use. The CTAB growth solution was prepared by the sequential addition of HAuCl<small><sub>4</sub></small> (0.01 M, 2 mL), AgNO<small><sub>3</sub></small> (0.01 M, 0.4 mL), HCl (1.0 M, 0.8 mL) and ascorbic acid (0.1 M, 0.32 mL) into the CTAB solution (0.1 M, 40 mL). After the solution was well mixed, the seed solution (40 μL) was rapidly added into the growth solution. The resultant solution was mixed by stirring for 30 s and was then kept at 30 °C overnight. After centrifugation (7000<span class="italic">g</span>, 10 min), the obtained pellet was redispersed in deionized water (40 mL).</span>

<h3 id="sect325"><span class="b_heading">2.2. Preparation of the GNR/TiO<small><sub>2</sub></small> nanostructures</span></h3>
<span>GNR/TiO<small><sub>2</sub></small> nanostructures were prepared as described in a previous report.<a title="Select to navigate to references" href="#cit28"><sup><span class="sup_ref">28</span></sup></a> The CTAB-capped GNRs were first coated with poly(sodium 4-styrenesulfonate) (PSS). Briefly, the CTAB-capped GNR solution (10 mL) was added dropwise into a PSS solution (molecular weight at 70<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>000, 2 g L<small><sup>−1</sup></small>, 6 mM NaCl, 10 mL) followed by stirring for 6 h. The excess PSS was removed by centrifugation (7000<span class="italic">g</span>, 10 min) twice, and the resultant pellet was redispersed into deionized water (0.2 mL). Then, a TiCl<small><sub>3</sub></small> solution (15 wt%, 0.2 mL, containing 20–30 wt% HCl) was added into deionized water (6 mL) under stirring, followed by the dropwise addition of NaHCO<small><sub>3</sub></small> (0.93 M, 1.35 mL) and immediate addition of the concentrated GNR/PSS solution (0.2 mL) into the mixture. After stirring for 30 min, the produced GNR/TiO<small><sub>2</sub></small> nanostructures were precipitated by centrifugation (6000<span class="italic">g</span>, 10 min) and redispersed in deionized water (10 mL).</span>

<h3 id="sect338"><span class="b_heading">2.3. Nanostructure characterization</span></h3>
<span>The extinction spectrum of the nanostructures was measured using a Hitachi U-3501 UV/visible/NIR spectrophotometer. The sizes and shapes of the synthesized nanostructures were characterized using an FEI Tecnai F20 microscope at 120 kV. The zeta potential and hydrodynamic size of the nanostructures were determined with a Malvern Zetasizer Nano ZS90 analyzer in deionized water. The concentration of the GNR/TiO<small><sub>2</sub></small> nanostructures was measured by an Agilent inductively coupled plasma mass spectrometry (ICP-MS) 7500a system.</span>

<h3 id="sect343"><span class="b_heading">2.4. Determination of the photothermal conversion efficiency</span></h3>
<span>An aqueous GNR/TiO<small><sub>2</sub></small> nanostructure solution (2 mL), with the optical density at 808 nm adjusted to 2.0, in a 1 cm square quartz cuvette was irradiated with an NIR laser (808 nm) at different power intensities (0.6, 1.0, or 1.4 W) for 30 min. The temperature of the solution was measured with a digital thermometer every 30 s. The probe of the thermometer was placed at such a position that the direct irradiation of the laser on the probe head was avoided. A cooling curve was obtained after the laser was switched off. The photothermal conversion efficiency was determined using a previously reported method.<a title="Select to navigate to references" href="#cit29"><sup><span class="sup_ref">29</span></sup></a></span>

<h3 id="sect349"><span class="b_heading">2.5. Cell culture</span></h3>
<span>Human glioblastoma U-87 MG cells were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA), and were cultured in alpha-modified Minimum Essential Medium (α-MEM, Thermo Fisher Scientific, Waltham, MA, USA) containing 10% fetal bovine serum (FBS), 100 U mL<small><sup>−1</sup></small> penicillin and 100 μg mL<small><sup>−1</sup></small> streptomycin at 37 °C in a humidified 5% CO<small><sub>2</sub></small> atmosphere.</span>

<h3 id="sect356"><span class="b_heading">2.6. Cell viability assay</span></h3>
<span>A CellTiter-Glo luminescent cell viability assay kit (Promega Corporation, Madison, WI, USA) was used to evaluate the cell viability. This is a homogeneous method to determine the number of viable cells, based on quantifying the adenosine triphosphate (ATP) present, which represents the presence of metabolically active cells. U-87 MG cells were seeded in the wells of a 96-well plate at a density of 5 × 10<small><sup>3</sup></small> cells per well in 100 μL α-MEM. After incubation for 12 h, the medium in the wells was replaced with a fresh medium containing GNR/TiO<small><sub>2</sub></small> nanostructures, GA or GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures. After incubation for 48 h, the cells were washed with phosphate buffered saline (PBS), and a fresh medium (100 μL) was added into each well. CellTiter-Glo reagent (100 μL) was then added to the wells, followed by shaking for 2 min on an orbital shaker. After further incubation for 10 min at room temperature to allow for stabilization of the luminescent signals, the solution from the wells was centrifuged (10<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>000<span class="italic">g</span>, 10 min). The collected supernatant (180 μL) was then transferred into each well of a 96-well white plate, and the luminescent signals were detected using a Molecular Devices SpectraMax Paradigm multi-mode microplate reader. The cell viability (%) was calculated for each sample relative to a control.</span>

<h3 id="sect364"><span class="b_heading">2.7. Cellular uptake observations</span></h3>
<span>Eight thousand cells were seeded into each well of a 24-well plate. After incubation for 12 h, the culture medium was replaced with a fresh medium containing the GNR/TiO<small><sub>2</sub></small> nanostructures (30 μg Au mL<small><sup>−1</sup></small>, 0.5 mL). After the cells were further incubated for 24 h, they were washed with PBS extensively to remove any nanoparticles adsorbed on the cell surface. The cellular uptake of the GNR/TiO<small><sub>2</sub></small> nanostructures was observed using an Olympus IX71 microscope under bright field.</span>

<h3 id="sect371"><span class="b_heading">2.8. Drug loading</span></h3>
<span>The GNR/TiO<small><sub>2</sub></small> nanostructures (750 μg Au mL<small><sup>−1</sup></small>, 0.1 mL) were centrifuged (6000<span class="italic">g</span>, 5 min) and washed with ethanol (0.2 mL). After centrifugation, the resulting pellet was redispersed in a 0.1 mL ethanol solution containing GA (200 μM, Sigma-Aldrich, St. Louis, MO, USA), followed by overnight stirring. The GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures were then obtained by centrifugation, and dispersed in the medium (0.1 mL) for further cell studies.</span>

<h3 id="sect379"><span class="b_heading">2.9. Drug loading capacity calculations</span></h3>
<span>After centrifugation (6000<span class="italic">g</span>, 10 min), the pellet of the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructure solution was mixed with dimethyl sulfoxide (DMSO, 0.1 mL), and sonicated for 30 min to dissolve the loaded drug. After centrifugation (12<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>000<span class="italic">g</span>, 10 min) of this solution, the GA concentration of the supernatant was determined according to the standard curve using an Agilent 6230 time-of-flight (TOF) liquid chromatography-mass spectrometry (LC/MS) system. The drug loading capacity was then calculated.</span>

<h3 id="sect386"><span class="b_heading">2.10. Drug desorption tests</span></h3>
<span>GA desorption from GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures was studied in NaOH (0.1 M), PBS (pH 7.4), or citrate buffer (20 mM, pH 4.5). The GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures (15 μg Au mL<small><sup>−1</sup></small>) were dispersed in the buffer (1 mL) at 37 °C for 24 h. After centrifugation (12<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>000 rpm, 10 min), the supernatant was collected, and the released GA in the supernatant was extracted three times using chloroform (0.5 mL). After the solvent was evaporated, the residual GA was dissolved with methanol (50 μL), and the GA concentration was determined using LC/MS. The drug desorption percentage was then calculated.</span>

<h3 id="sect393"><span class="b_heading">2.11. Intracellular GA content assay</span></h3>
<span>U-87 MG cells were cultured in 100 mm Petri dishes. When the cells reached 80% confluence, the culture medium was replaced with a fresh medium containing the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures or free GA at the equal GA concentration of 0.27 μM. After incubation for 24 h, the cells were washed with PBS, collected and counted. The cells were subsequently centrifuged at 4500<span class="italic">g</span> for 5 min. DMSO (0.1 mL) was used to extract the GA from the cell pellets. After centrifugation (12<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>000<span class="italic">g</span>, 10 min), the supernatant was collected and the GA concentration was determined using LC/MS. The GA amount per cell was then calculated.</span>

<h3 id="sect400"><span class="b_heading">2.12. Nuclei staining</span></h3>
<span>After the U-87 MG cells were incubated with the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures or free GA for 24 h, the cells were washed with PBS to remove any nanoparticles adsorbed on the cell surface. The nuclei of the cells were subsequently stained with Hoechst 33342 (100 ng mL<small><sup>−1</sup></small>, Thermo Fisher Scientific) for 30 min, and the cells were observed on an Olympus IX71 microscope.</span>

<h3 id="sect406"><span class="b_heading">2.13. Photothermal therapy</span></h3>
<span>Five thousand U-87 MG cells were seeded into each well of a 96-well plate. After incubation for 24 h, the culture medium was changed with phenol red-free α-MEM (100 μL) containing GA (0.27 μM), GNR/TiO<small><sub>2</sub></small> nanostructures (12.5 μg Au mL<small><sup>−1</sup></small>), or GA loaded GNR/TiO<small><sub>2</sub></small> nanostructures (0.27 μM GA, 12.5 μg Au mL<small><sup>−1</sup></small>), followed by further incubation for 24 h. The designated wells were exposed to a continuous-wave semiconductor diode laser (808 nm, MDL-N-808-10W, Changchun New Industries Optoelectronics Tech. Co., Ltd., China) for 2 min. The laser power density was 4.4, 5.3, 6.2 or 7.9 W cm<small><sup>−2</sup></small>, and the laser spot diameter was ∼6 mm, which is equal to the diameter of the bottom of a well on the 96-well plate. The cells were incubated for another 24 h, and ATP assay and calcein acetoxymethyl ester (calcein AM) staining were separately performed to determine the cell viability. After the treatment, the medium in the wells was replaced with serum-free α-MEM containing calcein AM (1 μM, Thermo Fisher Scientific). After incubation for 30 min, the cells were washed with fresh medium, and an Olympus IX71 microscope was used to capture images.</span>

<h3 id="sect415"><span class="b_heading">2.14. Statistical analysis</span></h3>
<span>Each experiment was repeated at least 3 times. Data are expressed as mean ± standard error of the mean (S.E.M.). The statistical difference was evaluated with one-way analysis of variance (ANOVA) followed by Tukey's post hoc test. A <span class="italic">P</span> value &lt;0.05 was considered as statistically significant.</span>


<h2 id="sect420"><span class="a_heading">3. Results and discussion</span></h2>
<h3 id="sect423"><span class="b_heading">3.1. Synthesis and characterization of the GNR/TiO<small><sub>2</sub></small> nanostructures</span></h3>
<span>GNR/CTAB nanostructures were prepared using a seed-mediated growth method.<a title="Select to navigate to references" href="#cit28"><sup><span class="sup_ref">28</span></sup></a> Transmission electron microscopy (TEM) imaging showed rod shapes with a narrow size distribution (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1a</a>). The length and diameter of the GNRs were determined to be 90 ± 4 nm and 29 ± 2 nm, respectively (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1a</a>). The zeta potential of the GNR/CTAB nanostructures was found to be +47 ± 7 mV. The GNRs were found to support two plasmon modes, a longitudinal and a transverse mode.<a title="Select to navigate to references" href="#cit20"><sup><span class="sup_ref">20</span></sup></a> The extinction spectrum of the GNR/CTAB in aqueous solution (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1c</a>) shows that the longitudinal and transverse plasmon resonance peaks are located at 742 nm and 526 nm, respectively. The GNR/TiO<small><sub>2</sub></small> nanostructures were prepared by employing TiCl<small><sub>3</sub></small> as the precursor.<a title="Select to navigate to references" href="#cit28"><sup><span class="sup_ref">28</span></sup></a> The zeta potential of the GNR/TiO<small><sub>2</sub></small> sample was determined to be −2 ± 2 mV. The TiO<small><sub>2</sub></small> coating with a thickness of 12 ± 1 nm (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1b</a>) induces a considerable red shift of the longitudinal plasmon resonance wavelength (LPRW) to 806 nm (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1c</a>), which is within the biological window of 650–900 nm.<a title="Select to navigate to references" href="#cit21"><sup><span class="sup_ref">21</span></sup></a> In addition, the hydrodynamic diameter of the GNR/TiO<small><sub>2</sub></small> nanostructures, measured by the dynamic light scattering technique, is 102 ± 18 nm. After incubation with the culture medium for 12 h, the size was determined to be 105 ± 21 nm, thus indicating that no particle aggregation occurred in the culture medium.</span>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2017/RA/c7ra08560e/c7ra08560e-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra08560e-f1.tif" src="/image/article/2017/RA/c7ra08560e/c7ra08560e-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">TEM images of GNR/CTAB (a) and GNR/TiO<small><sub>2</sub></small> (b) nanostructures, and (c) extinction spectra of the synthesized nanostructures.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>

<h3 id="sect445"><span class="b_heading">3.2. Photothermal conversion of the GNR/TiO<small><sub>2</sub></small> nanostructures</span></h3>
<span>Plasmonic gold nanostructures can absorb light and convert it into heat when irradiated with an NIR laser. This heat is thereafter transferred to the surrounding environment to cause a temperature increase. Gold nanostructure-based photothermal therapy has been previously employed to selectively ablate cancer cells,<a title="Select to navigate to references" href="#cit30"><sup><span class="sup_ref">30</span></sup></a> and trigger drug<a title="Select to navigate to references" href="#cit31"><sup><span class="sup_ref">31</span></sup></a> or gene release.<a title="Select to navigate to reference" href="#cit32"><sup><span class="sup_ref">32,33</span></sup></a> Generally, due to their higher photothermal conversion efficiency, gold nanostructures can cause an equal degree of cancer cell death at a lower concentration, a shorter irradiation time, and a lower laser power density. A high photothermal conversion efficiency of gold nanostructures is essential for achieving photothermal therapeutic effects.</span>
<p class="otherpara">To measure the photothermal conversion performance of the GNR/TiO<small><sub>2</sub></small> nanostructures, radiation from an 808 nm laser was sent through a quartz cuvette with a 1 cm path length containing an aqueous GNR/TiO<small><sub>2</sub></small> nanostructure dispersion (50 μg Au mL<small><sup>−1</sup></small>, 2 mL). The optical extinction of the dispersion at 808 nm was adjusted to 2.0, and a thermocouple was inserted into the aqueous dispersion at such a position that the direct irradiation of the laser on the probe was avoided. The temperature was recorded every 30 s after the laser had been turned on for 30 min until the temperature of the GNR/TiO<small><sub>2</sub></small> nanostructure dispersion solution reached a steady state. The solution was kept stirring during the measurements. The laser was then switched off and the temperature decrease profile was recorded to determine the rate of the heat transfer from the system to the environment. <a title="Select to navigate to figure" href="#imgfig2">Fig. 2a</a> shows the temperature rise traces of the GNR/TiO<small><sub>2</sub></small> nanostructures under 808 nm laser irradiation. The temperature increases rapidly in the beginning and then reaches a plateau after about 20 min of irradiation. After irradiation for 30 min with the 808 nm laser at a power of 1.4 W, the end temperature reaches 57.1 °C (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2b</a>).</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2017/RA/c7ra08560e/c7ra08560e-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra08560e-f2.tif" src="/image/article/2017/RA/c7ra08560e/c7ra08560e-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">Photothermal conversion of GNR/TiO<small><sub>2</sub></small> nanostructures. (a) Temperature rise curves of the GNR/TiO<small><sub>2</sub></small> nanostructures in water (50 μg Au mL<small><sup>−1</sup></small>, 2 mL) acquired under 808 nm laser irradiation at various laser powers for 30 min. (b) Plateau temperatures reached as a function of the laser power. (c) Temperature decay. The data points were measured during the cooling process after the GNR/TiO<small><sub>2</sub></small> nanostructure solution (50 μg Au mL<small><sup>−1</sup></small>, 2 mL) was irradiated with the 808 nm laser at 1.4 W for 30 min. The blue line was obtained from fitting.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">A previously-reported theoretical model<a title="Select to navigate to references" href="#cit29"><sup><span class="sup_ref">29</span></sup></a> was used to determine the photothermal conversion efficiency <span class="italic">η</span> according to the following <a title="" href="#eqn1">eqn (1)</a>:<table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn1"/>
<a href="/image/article/2017/RA/c7ra08560e/c7ra08560e-t1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra08560e-t1.tif" src="/image/article/2017/RA/c7ra08560e/c7ra08560e-t1.gif"/></a></td><td class="rightEqn">(1)</td></tr></table>where <span class="italic">I</span> = 0.6, 1.0 or 1.4 W is the laser output power value, and <span class="italic">E</span> is the extinction value at 808 nm, which has been adjusted to 2.0. <span class="italic">B</span> and <span class="italic">C</span> are two coefficients characterizing the temperature-dependent thermal loss of the entire system. They can be determined by fitting the temperature decay curve (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2c</a>). The determined <span class="italic">B</span> and <span class="italic">C</span> values are 1.876 J K<small><sup>−1</sup></small> min<small><sup>−1</sup></small> and 0.00352 J K<small><sup>−2</sup></small> min<small><sup>−1</sup></small>, respectively. <span class="italic">T</span><small><sub>0</sub></small> is the temperature of the solution before the laser irradiation, and <span class="italic">T</span><small><sub>end</sub></small> is the steady temperature reached under the laser irradiation. <span class="italic">ξ</span> is the fraction of the laser energy absorbed by the cuvette walls and the solution, which was determined to be 0.0411 by measuring the temperature rise and decay curves of pure water. According to <a title="" href="#eqn1">eqn (1)</a>, we obtained a photothermal conversion efficiency of 85.3 ± 4.4% for the GNR/TiO<small><sub>2</sub></small> nanostructures under the 808 nm laser irradiation.</p>

<h3 id="sect493"><span class="b_heading">3.3. Cellular uptake and cytotoxicity of the GNR/TiO<small><sub>2</sub></small> nanostructures</span></h3>
<span>As an anticancer drug carrier, efficient internalization by cancer cells and biocompatibility should be considered to be of utmost importance.<a title="Select to navigate to reference" href="#cit34"><sup><span class="sup_ref">34,35</span></sup></a> Glioblastoma is one of the most aggressive cancers, and the anticancer effect of GA on glioblastoma has attracted increasing attention.<a title="Select to navigate to references" href="#cit1"><sup><span class="sup_ref">1</span></sup></a> In this study, cellular uptake and cytotoxicity of GNR/TiO<small><sub>2</sub></small> nanostructures were studied in human glioblastoma U-87 MG cells. Bright field imaging under an inverted microscope was used as a simple method to evaluate the cellular uptake of GNR/TiO<small><sub>2</sub></small> nanostructures, and they show a dark red color. As shown in <a title="Select to navigate to figure" href="#imgfig3">Fig. 3a</a>, the GNR/TiO<small><sub>2</sub></small> nanostructures are readily internalized by U-87 MG cells, and most of the nanostructures were observed in the cytoplasm around the nuclei. In addition, endosome/lysosome staining with LysoSensor Green (Fig. S1<a title="Select to navigate to footnote" href="#fn1">†</a>) shows that internalized GNR/TiO<small><sub>2</sub></small> nanostructures are mainly located in the endosomes/lysosomes. After treatment for 48 hours with the GNR/TiO<small><sub>2</sub></small> nanostructures (0–150 μg Au mL<small><sup>−1</sup></small>), no obvious cytotoxicity was observed in the U-87 MG cells (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3b</a>), indicating that the GNR/TiO<small><sub>2</sub></small> nanostructures are biocompatible.</span>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><a href="/image/article/2017/RA/c7ra08560e/c7ra08560e-f3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra08560e-f3.tif" src="/image/article/2017/RA/c7ra08560e/c7ra08560e-f3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">Cellular uptake and cytotoxicity of GNR/TiO<small><sub>2</sub></small> nanostructures. (a) Bright field imaging of U-87 MG cells after incubation with GNR/TiO<small><sub>2</sub></small> nanostructures (30 μg Au mL<small><sup>−1</sup></small>). Dark red GNR/TiO<small><sub>2</sub></small> granules are evident in the cytoplasm around the nuclei of cells. (b) Effect of GNR/TiO<small><sub>2</sub></small> nanostructures on U-87 MG cell viability. U-87 MG cells were exposed to varying concentrations (0–150 μg Au mL<small><sup>−1</sup></small>) of GNR/TiO<small><sub>2</sub></small> nanostructures for 48 h, followed by an ATP assay. The data shown represent the mean ± S.E.M.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>

<h3 id="sect519"><span class="b_heading">3.4. Photothermal therapy study</span></h3>
<span>Hyperthermia induces cell death at temperatures above 43 °C.<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a> Compared with common hyperthermia therapy, photothermal therapy is able to noninvasively and selectively ablate cancer cells. Efficient light absorption and photothermal conversion in the NIR region enables GNRs to denature cell proteins and therefore cause irreversible cell death upon light irradiation.<a title="Select to navigate to references" href="#cit37"><sup><span class="sup_ref">37</span></sup></a> Nanostructure-based photothermal therapeutic effects have previously been found to be highly dependent on the irradiation power density and duration. In this study, solo irradiation with the 808 nm laser at the power density of 7.9 W cm<small><sup>−2</sup></small> for 2 min did not affect the cell viability of U-87 MG cells. Irradiation with the 808 nm laser for 2 min at the power density of 6.2 and 7.9 W cm<small><sup>−2</sup></small> in the presence of the GNR/TiO<small><sub>2</sub></small> nanostructures reduced the cell viability of U-87 MG cells to 48.7 ± 5.2% and 25.0 ± 6.1%, respectively (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4a</a>). In addition, calcein AM staining was also used to confirm this result. Calcein AM can reveal the ubiquitous intracellular esterase activity inside live cells, and therefore only live cells are stained with green fluorescence.<a title="Select to navigate to references" href="#cit38"><sup><span class="sup_ref">38</span></sup></a> Most cells in the control group display green fluorescence and maintain their normal morphology. In contrast, rounding of the cell morphology was clearly observed for the cells after laser irradiation at 6.2 W cm<small><sup>−2</sup></small> in the presence of the GNR/TiO<small><sub>2</sub></small> nanostructures. The green fluorescence was almost undetectable after laser irradiation at 7.9 W cm<small><sup>−2</sup></small>, indicating that the irradiation power density of 7.9 W cm<small><sup>−2</sup></small> is able to kill most of the U-87 MG cells (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4b</a>). A low irradiation dose (5.3 W cm<small><sup>−2</sup></small>, 2 min) was chosen in the following experiments.</span>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig4"><a href="/image/article/2017/RA/c7ra08560e/c7ra08560e-f4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra08560e-f4.tif" src="/image/article/2017/RA/c7ra08560e/c7ra08560e-f4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 4 </b> <span id="fig4"><span class="graphic_title">Cell viability of U-87 MG cells upon photothermal therapy. U-87 MG cells were incubated with the GNR/TiO<small><sub>2</sub></small> nanostructures at the concentration of 12.5 μg Au mL<small><sup>−1</sup></small> for 24 h, followed by 808 nm NIR laser irradiation at 4.4, 5.3, 6.2 or 7.9 W cm<small><sup>−2</sup></small> for 2 min. The cell viability was determined by (a) ATP assay or (b) calcein AM staining after further incubation for 24 h. Live cells were stained with green fluorescence by calcein AM. The data shown represent the mean ± S.E.M., *<span class="italic">P</span> &lt; 0.05, ***<span class="italic">P</span> &lt; 0.001.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>

<h3 id="sect543"><span class="b_heading">3.5. Loading GA onto GNR/TiO<small><sub>2</sub></small> nanostructures</span></h3>
<span>Carboxylic acid has a high binding affinity to TiO<small><sub>2</sub></small>,<a title="Select to navigate to references" href="#cit27"><sup><span class="sup_ref">27</span></sup></a> so we then tried to use the GNR/TiO<small><sub>2</sub></small> nanostructures as the delivery carrier for the GA molecule, which has a carboxylic group (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5a</a>). The drug loading was performed in ethanol. The obtained GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures were well dispersible in water (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5b</a>). The GA loading capacity of the GNR/TiO<small><sub>2</sub></small> nanostructures was calculated to be 1.33 ± 0.1%, according to the following <a title="" href="#eqn2">eqn (2)</a>.<table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn2"/>
<a href="/image/article/2017/RA/c7ra08560e/c7ra08560e-t2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra08560e-t2.tif" src="/image/article/2017/RA/c7ra08560e/c7ra08560e-t2.gif"/></a></td><td class="rightEqn">(2)</td></tr></table></span>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig5"><a href="/image/article/2017/RA/c7ra08560e/c7ra08560e-f5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra08560e-f5.tif" src="/image/article/2017/RA/c7ra08560e/c7ra08560e-f5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 5 </b> <span id="fig5"><span class="graphic_title">GA loading. (a) Chemical structure of GA. (b) GA and GA-loaded GNR/TiO<small><sub>2</sub></small> suspensions in water. (c) Desorption of GA in NaOH and PBS. GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures (15 μg Au mL<small><sup>−1</sup></small>) were dispersed in 1 mL of NaOH (0.1 M) or PBS (pH 7.4) for 24 h. The drug desorption percentage was calculated by measuring the drug concentration of the supernatant. The data shown represent the mean ± S.E.M.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">Alkaline solutions are effective agents for desorbing carboxylic acid molecules from the surface of TiO<small><sub>2</sub></small>.<a title="Select to navigate to reference" href="#cit39"><sup><span class="sup_ref">39,40</span></sup></a> To evaluate the binding between GA and TiO<small><sub>2</sub></small>, GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures were immersed in a basic aqueous solution (NaOH, 0.1 M) for 24 h. 79.6 ± 4.3% of GA was stripped from the TiO<small><sub>2</sub></small> surfaces as shown in <a title="Select to navigate to figure" href="#imgfig5">Fig. 5c</a>. However, only 6.8 ± 3.7% of GA desorbed from the GNR/TiO<small><sub>2</sub></small> nanostructures in PBS (pH 7.4). We assumed that the dramatic GA desorption in the NaOH solution is due to the carboxylic acid group of GA reacting with NaOH and it being converted into a water-soluble salt. As the internalized nanoparticles are mainly distributed in the acidic endosomes/lysosomes, we also studied the GA desorption in endosome/lysosome mimicking buffer (20 mM citrate, pH 4.5).<a title="Select to navigate to references" href="#cit41"><sup><span class="sup_ref">41</span></sup></a> 18.6 ± 3.1% of GA released from the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures was observed after incubation for 24 h. This result is attributed to the fact that citric acid is able to competitively displace GA from the GNR/TiO<small><sub>2</sub></small> nanostructures, as it also has carboxylic acid groups.</p>

<h3 id="sect575"><span class="b_heading">3.6. Enhanced cytotoxicity of the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures</span></h3>
<span>As the GNR/TiO<small><sub>2</sub></small> nanostructures are readily internalized by U-87 MG cells, we speculated that the GNR/TiO<small><sub>2</sub></small> nanostructures are able to carry more GA into these cells than free GA. We compared the intracellular GA content of the cells treated with free GA and those treated with the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures at the same drug concentration. After GA was extracted from the cells with the organic solvent, the GA concentration was analyzed using LC/MS, which is suitable for detecting GA at a very low concentration range. As shown in <a title="Select to navigate to figure" href="#imgfig6">Fig. 6a</a>, after incubation of 0.27 μM GA for 24 h, the intracellular GA content of cells that underwent the free-form treatment was (9.6 ± 2.2) × 10<small><sup>−17</sup></small> g per cell. On the other hand, this value was determined to be (6.0 ± 0.7) × 10<small><sup>−16</sup></small> g per cell for the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructure treatment group (<span class="italic">P</span> &lt; 0.001). This result indicated that the GNR/TiO<small><sub>2</sub></small> nanostructures can increase the concentration of GA in the cancer cells compared with the free form, and therefore, they offer the possibility of higher therapeutic efficacy.</span>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig6"><a href="/image/article/2017/RA/c7ra08560e/c7ra08560e-f6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra08560e-f6.tif" src="/image/article/2017/RA/c7ra08560e/c7ra08560e-f6.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 6 </b> <span id="fig6"><span class="graphic_title">Comparison of the cytotoxic effects of free GA and GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures. (a) Intracellular GA content. U-87 MG cells were treated with free GA or GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures at a GA concentration of 0.27 μM for 24 h, and the intracellular GA content was determined using LC/MS. (b) Effect of GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures and free GA on cell viability of U-87 MG cells. U-87 MG cells were treated with free GA or GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures at various GA concentrations for 48 h, followed by ATP assay. (c) Effect of GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures and free GA on DNA fragmentation in U-87 MG cells. After incubation for 24 h, the cells were stained with 100 ng mL<small><sup>−1</sup></small> Hoechst 33342. The data shown represent the mean ± S.E.M., ***<span class="italic">P</span> &lt; 0.001.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">The cytotoxic effect of the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures was also compared with that of the free GA. Both GA and the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures showed an apparent dose-dependent cytotoxicity in U-87 MG cells, as shown in <a title="Select to navigate to figure" href="#imgfig6">Fig. 6b</a>. Enhanced cytotoxicity was achieved by using GNR/TiO<small><sub>2</sub></small> nanostructure-based intracellular delivery. After incubation for 48 h with 1 μM GA, the cell viability of the U-87 MG cells was 84.7 ± 5.2%. However, for the cells treated with the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures at the same drug concentration, the cell viability was reduced to 41.0 ± 5.2% (<span class="italic">P</span> &lt; 0.001). We further used a cell-permeable DNA dye, Hoechst 33342, to stain the DNA of the cells. The GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures (0.33 μM GA, 24 h) caused cell shrinkage with an intact cell membrane, chromosome condensation and DNA fragmentation (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6c</a>). No lactate dehydrogenase (LDH) was detected in the culture medium. These results indicate that cell apoptosis rather than necrosis was induced by the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures. However, U-87 MG cells treated with free GA (0.67 μM) showed an intact nuclear architecture (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6c</a>). A similar result was obtained in one of our previous studies, where enhanced cellular uptake and cytotoxicity of hydrophobic anticancer drugs were achieved by using hollow superparamagnetic iron oxide (SPIO) nanoshells as the drug carrier.<a title="Select to navigate to references" href="#cit41"><sup><span class="sup_ref">41</span></sup></a> These results suggest that owing to the ability of the GNR/TiO<small><sub>2</sub></small> nanostructures to carry more drug into the cells, they significantly enhance the cytotoxicity of GA.</p>

<h3 id="sect611"><span class="b_heading">3.7. Photothermal therapy-enhanced cytotoxicity of GA</span></h3>
<span>In some cases, hyperthermia therapy is performed at a moderately elevated temperature,<a title="Select to navigate to references" href="#cit42"><sup><span class="sup_ref">42</span></sup></a> and it synergistically enhances the anticancer effects of chemotherapeutic agents.<a title="Select to navigate to reference" href="#cit43"><sup><span class="sup_ref">43,44</span></sup></a> The results from a recent clinical study indicate that a combination of hyperthermia and chemotherapy results in a higher survival rate for the non-muscle-invasive bladder cancer patients.<a title="Select to navigate to references" href="#cit45"><sup><span class="sup_ref">45</span></sup></a> The photothermal therapy-mediating agents encapsulated with anticancer drugs can deliver both drugs and heat simultaneously to the tumor. This multi-modal treatment strategy can result in additionally enhanced anticancer efficacy.<a title="Select to navigate to references" href="#cit46"><sup><span class="sup_ref">46</span></sup></a> The mechanisms for chemo-sensitization with hyperthermia include enhanced reactive oxygen species production, inhibition of DNA repair, and increased intracellular drug accumulation.<a title="Select to navigate to references" href="#cit42"><sup><span class="sup_ref">42</span></sup></a></span>
<p class="otherpara">In this regard, we examined the efficacy of GNR/TiO<small><sub>2</sub></small> nanostructure-mediated photothermal therapy in combination with GA. Here, a low irradiation dose (5.3 W cm<small><sup>−2</sup></small>, 2 min) and a low GA dose (0.27 μM, 48 h) were used in this experiment. The cell viabilities after these two treatments were 96.7 ± 0.9% and 97.3 ± 0.9%, respectively (<a title="Select to navigate to figure" href="#imgfig7">Fig. 7a</a>). The GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures (0.27 μM GA, 48 h) slightly reduced the viability to 78.0 ± 3.8%. GNR/TiO<small><sub>2</sub></small> nanostructure-based photothermal therapy at the same irradiation dose (5.3 W cm<small><sup>−2</sup></small>, 2 min) also reduced the cell viability to 83.3 ± 0.6%. However, a combination of the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures and photothermal therapy reduced the cell viability to 42.7 ± 1.8% in a synergistic manner (<a title="Select to navigate to figure" href="#imgfig7">Fig. 7a</a>). This result was also confirmed by calcein AM staining. Almost all of the cells became rounded and green fluorescence was not detectable for most cells after the combined treatment. In contrast, most cells after receiving the mono-therapy alone displayed green fluorescence and maintained their normal morphology (<a title="Select to navigate to figure" href="#imgfig7">Fig. 7b</a>). Our results indicate that the application of GNR/TiO<small><sub>2</sub></small> nanostructure-based photothermal therapy synergistically enhances the anticancer effect of GA.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig7"><a href="/image/article/2017/RA/c7ra08560e/c7ra08560e-f7_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra08560e-f7.tif" src="/image/article/2017/RA/c7ra08560e/c7ra08560e-f7.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 7 </b> <span id="fig7"><span class="graphic_title">Enhanced cytotoxic effect of GA by using GNR/TiO<small><sub>2</sub></small> nanostructure-mediated photothermal therapy. U-87 MG cells were incubated with GNR/TiO<small><sub>2</sub></small> or GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures at the GA concentration of 0.27 μM for 24 h, followed by 808 nm NIR irradiation (5.3 W cm<small><sup>−2</sup></small>) for 2 min. After incubation for 24 h, cell viability was determined using an ATP assay (a) and calcein AM staining (b). Live cells were stained with green fluorescence by calcein AM. The data shown represent the mean ± S.E.M., ***<span class="italic">P</span> &lt; 0.001.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">Chemotherapy dose has a direct impact on cancer patient outcomes.<a title="Select to navigate to references" href="#cit47"><sup><span class="sup_ref">47</span></sup></a> Although the risk of toxicity from intensive chemotherapy should be considered, inadequate treatment that might induce tumor recurrence should be avoided. In view of this fact, the incorporation of GNR/TiO<small><sub>2</sub></small> nanostructure-mediated photothermal therapy with chemotherapy will be useful for improving the efficacy of GA. This combined treatment provides the possibility of reducing the GA dosage or achieving enhanced anticancer effects.</p>


<h2 id="sect641"><span class="a_heading">4. Conclusions</span></h2>
<span>In summary, GNR/TiO<small><sub>2</sub></small> nanostructures as an intracellular carrier for GA were reported for the first time. This delivery approach provides a stable aqueous dispersion of GA. Compared with the free GA, the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures induce a higher intracellular GA content and superior cytotoxicity. In addition, the GNR/TiO<small><sub>2</sub></small> nanostructures show a high photothermal conversion efficiency under 808 nm NIR laser irradiation. Photothermal therapy at a low irradiation dose (5.3 W cm<small><sup>−2</sup></small>, 2 min) further synergistically enhances the anticancer effects of the GA-loaded GNR/TiO<small><sub>2</sub></small> nanostructures. Our results suggest that the GNR/TiO<small><sub>2</sub></small> nanostructures will offer great potential for GA delivery.</span>

<h2 id="sect651"><span class="a_heading">Conflicts of interest</span></h2>
<span>The authors declare no competing financial interests.</span>


<h2 id="sect655"><span class="a_heading">Acknowledgements</span></h2><span>This work was supported by Macau Science and Technology Development Fund (Project No. 014/2014/A1).</span>
<span id="sect657"><h2 id="sect654"><span class="a_heading">References</span></h2></span><ol type="1"><li><span id="cit1">L. Qiang, Y. Yang, Q.-D. You, Y.-J. Ma, L. Yang, F.-F. Nie, H.-Y. Gu, L. Zhao, N. Lu, Q. Qi, W. Liu, X.-T. Wang and Q.-L. Guo, <span class="italic">Biochem. Pharmacol.</span>, 2008, <span class="bold">75</span>, 1083–1092 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.bcp.2007.10.033" title="DOI Link to resource 10.1016/j.bcp.2007.10.033">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhvVWgtr8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18070617%5Buid%5D" title="PubMed Link to resource 18070617">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/1_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit2">L.-H. Wang, Y. Li, S.-N. Yang, F.-Y. Wang, Y. Hou, W. Cui, K. Chen, Q. Cao, S. Wang, T.-Y. Zhang, Z.-Z. Wang, W. Xiao, J.-Y. Yang and C.-F. Wu, <span class="italic">Br. J. Cancer</span>, 2014, <span class="bold">110</span>, 341–352 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/bjc.2013.752" title="DOI Link to resource 10.1038/bjc.2013.752">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCqsbbJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24300974%5Buid%5D" title="PubMed Link to resource 24300974">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/2_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit3">D. Z. Duan, B. X. Zhang, J. Yao, Y. P. Liu, J. Y. Sun, C. P. Ge, S. J. Peng and J. G. Fang, <span class="italic">Free Radical Biol. Med.</span>, 2014, <span class="bold">69</span>, 15–25 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.freeradbiomed.2013.12.027" title="DOI Link to resource 10.1016/j.freeradbiomed.2013.12.027">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXksVWnsbk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24407164%5Buid%5D" title="PubMed Link to resource 24407164">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/3_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit4">L. L. Liang and Z. X. Zhang, <span class="italic">Cell. Physiol. Biochem.</span>, 2016, <span class="bold">38</span>, 1618–1630 <a target="_blank" class="DOILink" href="https://doi.org/10.1159/000443102" title="DOI Link to resource 10.1159/000443102">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XmvFOitr8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27119348%5Buid%5D" title="PubMed Link to resource 27119348">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/4_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit5">X. P. Shi, X. Chen, X. F. Li, X. Y. Lan, C. Zhao, S. T. Liu, H. B. Huang, N. N. Liu, S. Y. Liao, W. B. Song, P. Zhou, S. Q. Wang, L. Xu, X. J. Wang, Q. P. Dou and J. B. Liu, <span class="italic">Clin. Cancer Res.</span>, 2014, <span class="bold">20</span>, 151–163 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/1078-0432.CCR-13-1063" title="DOI Link to resource 10.1158/1078-0432.CCR-13-1063">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXislKltw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24334603%5Buid%5D" title="PubMed Link to resource 24334603">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/5_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit6">P. van Hoogevest, X. L. Liu and A. Fahr, <span class="italic">Expert Opin. Drug Delivery</span>, 2011, <span class="bold">8</span>, 1481–1500 <a target="_blank" class="DOILink" href="https://doi.org/10.1517/17425247.2011.614228" title="DOI Link to resource 10.1517/17425247.2011.614228">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGitrnK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21895540%5Buid%5D" title="PubMed Link to resource 21895540">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/6_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit7">N. Bertrand, J. Wu, X. Y. Xu, N. Kamaly and O. C. Farokhzad, <span class="italic">Adv. Drug Delivery Rev.</span>, 2014, <span class="bold">66</span>, 2–25 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2013.11.009" title="DOI Link to resource 10.1016/j.addr.2013.11.009">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXisV2hug%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24270007%5Buid%5D" title="PubMed Link to resource 24270007">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/7_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit8">I.-P. Huang, S.-P. Sun, S.-H. Cheng, C.-H. Lee, C.-Y. Wu, C.-S. Yang, L.-W. Lo and Y.-K. Lai, <span class="italic">Mol. Cancer Ther.</span>, 2011, <span class="bold">10</span>, 761–769 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/1535-7163.MCT-10-0884" title="DOI Link to resource 10.1158/1535-7163.MCT-10-0884">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXlslKgtrs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21411714%5Buid%5D" title="PubMed Link to resource 21411714">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/8_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit9">X. W. Dong, C. A. Mattingly, M. T. Tseng, M. J. Cho, Y. Liu, V. R. Adams and R. J. Mumper, <span class="italic">Cancer Res.</span>, 2009, <span class="bold">69</span>, 3918–3926 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/0008-5472.CAN-08-2747" title="DOI Link to resource 10.1158/0008-5472.CAN-08-2747">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXltFOksb4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19383919%5Buid%5D" title="PubMed Link to resource 19383919">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/9_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit10">M. R. Green, G. M. Manikhas, S. Orlov, B. Afanasyev, A. M. Makhson, P. Bhar and M. J. Hawkins, <span class="italic">Ann. Oncol.</span>, 2006, <span class="bold">17</span>, 1263–1268 <a target="_blank" class="DOILink" href="https://doi.org/10.1093/annonc/mdl104" title="DOI Link to resource 10.1093/annonc/mdl104">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BD28vkvVOrsw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16740598%5Buid%5D" title="PubMed Link to resource 16740598">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/10_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit11">E. Miele, G. P. Spinelli, E. Miele, F. Tomao and S. Tomao, <span class="italic">Int. J. Nanomed.</span>, 2009, <span class="bold">4</span>, 99–105 <a target="_blank" class="DOILink" href="https://doi.org/10.1504/IJNM.2009.028116" title="DOI Link to resource 10.1504/IJNM.2009.028116">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKjsrrM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/11_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit12">W. Z. Huang, X. Wang, C. Y. Shi, D. D. Guo, G. F. Xu, L. L. Wang, A. Bodman and J. T. Luo, <span class="italic">Mol. Pharmaceutics</span>, 2015, <span class="bold">12</span>, 1216–1229 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.molpharmaceut.5b00051" title="DOI Link to resource 10.1021/acs.molpharmaceut.5b00051">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXivFGksrc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25692376%5Buid%5D" title="PubMed Link to resource 25692376">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/12_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit13">G. W. Qu, X. Zhu, C. Zhang and Q. N. Ping, <span class="italic">Drug Delivery</span>, 2009, <span class="bold">16</span>, 363–370 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/10717540903075545" title="DOI Link to resource 10.1080/10717540903075545">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWju77O" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19575591%5Buid%5D" title="PubMed Link to resource 19575591">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/13_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit14">L. L. Cai, N. Qiu, M. L. Xiang, R. S. Tong, J. F. Yan, L. He, J. Y. Shi, T. Chen, J. L. Wen, W. W. Wang and L. J. Chen, <span class="italic">Int. J. Nanomed.</span>, 2014, <span class="bold">9</span>, 243–255 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Int.%20J.%20Nanomed.%5BJour%5D%20AND%209%5Bvolume%5D%20AND%20243%5Bpage%5D%20and%202014%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/14_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit15">Y. Ding, Y. Z. Wang, Y. Opoku-Damoah, C. Wang, L. J. Shen, L. F. Yin and J. P. Zhou, <span class="italic">Biomaterials</span>, 2015, <span class="bold">72</span>, 90–103 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2015.08.051" title="DOI Link to resource 10.1016/j.biomaterials.2015.08.051">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhsVaqs7rL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26344366%5Buid%5D" title="PubMed Link to resource 26344366">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/15_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit16">H. Gelderblom, J. Verweij, K. Nooter and A. Sparreboom, <span class="italic">Eur. J. Cancer</span>, 2001, <span class="bold">37</span>, 1590–1598 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0959-8049(01)00171-X" title="DOI Link to resource 10.1016/S0959-8049(01)00171-X">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3MXmt1Oqtb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11527683%5Buid%5D" title="PubMed Link to resource 11527683">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/16_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit17">S. Her, D. A. Jaffray and C. Allen, <span class="italic">Adv. Drug Delivery Rev.</span>, 2017, <span class="bold">109</span>, 84–101 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2015.12.012" title="DOI Link to resource 10.1016/j.addr.2015.12.012">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXitV2kurjM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26712711%5Buid%5D" title="PubMed Link to resource 26712711">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/17_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit18">A. M. Alkilany, L. B. Thompson, S. P. Boulos, P. N. Sisco and C. J. Murphy, <span class="italic">Adv. Drug Delivery Rev.</span>, 2012, <span class="bold">64</span>, 190–199 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2011.03.005" title="DOI Link to resource 10.1016/j.addr.2011.03.005">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xkt1CqsL8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21397647%5Buid%5D" title="PubMed Link to resource 21397647">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/18_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit19">C. M. Cobley, J. Y. Chen, E. C. Cho, L. V. Wang and Y. N. Xia, <span class="italic">Chem. Soc. Rev.</span>, 2011, <span class="bold">40</span>, 44–56 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B821763G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B821763G">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/19_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit20">H. J. Chen, L. Shao, Q. Li and J. F. Wang, <span class="italic">Chem. Soc. Rev.</span>, 2013, <span class="bold">42</span>, 2679–2724 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2CS35367A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2CS35367A">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/20_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit21">R. A. Weissleder, <span class="italic">Nat. Biotechnol.</span>, 2001, <span class="bold">19</span>, 316–317 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/86684" title="DOI Link to resource 10.1038/86684">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3MXis1SmsLg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11283581%5Buid%5D" title="PubMed Link to resource 11283581">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/21_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit22">J. B. Song, X. Y. Yang, O. Jacobson, L. S. Lin, P. Huang, G. Niu, Q. J. Ma and X. Y. Chen, <span class="italic">ACS Nano</span>, 2015, <span class="bold">9</span>, 9199–9209 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.5b03804" title="DOI Link to resource 10.1021/acsnano.5b03804">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2mtbjI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26308265%5Buid%5D" title="PubMed Link to resource 26308265">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/22_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit23">J. F. Liao, W. T. Li, J. R. Peng, Q. Yang, H. Li, Y. Q. Wei, X. N. Zhang and Z. Y. Qian, <span class="italic">Theranostics</span>, 2015, <span class="bold">5</span>, 345–356 <a target="_blank" class="DOILink" href="https://doi.org/10.7150/thno.10731" title="DOI Link to resource 10.7150/thno.10731">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25699095%5Buid%5D" title="PubMed Link to resource 25699095">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/23_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit24">N. Larson, A. Gormley, N. Frazier and H. Ghandehari, <span class="italic">J. Controlled Release</span>, 2013, <span class="bold">170</span>, 41–50 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2013.04.006" title="DOI Link to resource 10.1016/j.jconrel.2013.04.006">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhtVaku7rL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23602864%5Buid%5D" title="PubMed Link to resource 23602864">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/24_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit25">J. Nowotny, M. A. Alim, T. Bak, M. A. Idris, M. Ionescu, K. Prince, M. Z. Sahdan, K. Sopian, M. A. Mat Teridi and W. Sigmund, <span class="italic">Chem. Soc. Rev.</span>, 2015, <span class="bold">44</span>, 8424–8442 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4CS00469H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4CS00469H">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/25_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit26">J. Schneider, M. Matsuoka, M. Takeuchi, J. L. Zhang, Y. Horiuchi, M. Anpo and D. W. Bahnemann, <span class="italic">Chem. Rev.</span>, 2014, <span class="bold">114</span>, 9919–9986 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr5001892" title="DOI Link to resource 10.1021/cr5001892">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyjtb7L" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25234429%5Buid%5D" title="PubMed Link to resource 25234429">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/26_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit27">Q. Y. Qu, H. W. Geng, R. X. Peng, Q. Cui, X. H. Gu, F. Q. Li and M. T. Wang, <span class="italic">Langmuir</span>, 2010, <span class="bold">26</span>, 9539–9546 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/la100121n" title="DOI Link to resource 10.1021/la100121n">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXjvFequ7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20345108%5Buid%5D" title="PubMed Link to resource 20345108">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/27_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit28">X.-M. Zhu, C. H. Fang, H. L. Jia, Y. Huang, C. H. K. Cheng, C.-H. Ko, Z. Y. Chen, J. F. Wang and Y.-X. J. Wang, <span class="italic">Nanoscale</span>, 2014, <span class="bold">6</span>, 11462–11472 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4NR03865G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4NR03865G">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/28_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit29">H. J. Chen, L. Shao, T. Ming, Z. H. Sun, C. M. Zhao, B. C. Yang and J. F. Wang, <span class="italic">Small</span>, 2010, <span class="bold">6</span>, 2272–2280 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.201001109" title="DOI Link to resource 10.1002/smll.201001109">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXht1yktbnF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20827680%5Buid%5D" title="PubMed Link to resource 20827680">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/29_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit30">X. H. Huang, I. H. El-Sayed, W. Qian and M. A. El-Sayed, <span class="italic">J. Am. Chem. Soc.</span>, 2006, <span class="bold">128</span>, 2115–2120 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja057254a" title="DOI Link to resource 10.1021/ja057254a">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XntFCltQ%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16464114%5Buid%5D" title="PubMed Link to resource 16464114">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/30_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit31">W.-H. Chen, C.-X. Yang, W.-X. Qiu, G.-F. Luo, H.-Z. Jia, Q. Lei, X.-Y. Wang, G. Liu, R.-X. Zhuo and X.-Z. Zhang, <span class="italic">Adv. Healthcare Mater.</span>, 2015, <span class="bold">4</span>, 2247–2259 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adhm.201500453" title="DOI Link to resource 10.1002/adhm.201500453">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhsVensb3N" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26333115%5Buid%5D" title="PubMed Link to resource 26333115">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/31_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit32">J. Song, K. Im, S. Hwang, J. Hur, J. Nam, G.-O. Ahn, S. Hwang, S. Kim and N. Park, <span class="italic">Nanoscale</span>, 2015, <span class="bold">7</span>, 9433–9437 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5NR00858A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5NR00858A">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/32_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit33">A. M. Goodman, N. J. Hogan, S. Gottheim, C. Li, S. E. Clare and N. J. Halas, <span class="italic">ACS Nano</span>, 2017, <span class="bold">11</span>, 171–179 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.6b06510" title="DOI Link to resource 10.1021/acsnano.6b06510">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhvFSitLzJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28114757%5Buid%5D" title="PubMed Link to resource 28114757">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/33_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit34">F. Zhao, Y. Zhao, Y. Liu, X. L. Chang, C. Y. Chen and Y. L. Zhao, <span class="italic">Small</span>, 2011, <span class="bold">7</span>, 1322–1337 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.201100001" title="DOI Link to resource 10.1002/smll.201100001">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXmtleiu78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21520409%5Buid%5D" title="PubMed Link to resource 21520409">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/34_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit35">B. Yameen, W. I. Choi, C. Vilos, A. Swami, J. J. Shi and O. C. Farokhzad, <span class="italic">J. Controlled Release</span>, 2014, <span class="bold">190</span>, 485–499 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2014.06.038" title="DOI Link to resource 10.1016/j.jconrel.2014.06.038">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSqtbjI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24984011%5Buid%5D" title="PubMed Link to resource 24984011">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/35_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit36">B. Hildebrandt, P. Wust, O. Ahlers, A. Dieing, G. Sreenivasa, T. Kerner, R. Felix and H. Riess, <span class="italic">Crit. Rev. Oncol. Hematol.</span>, 2002, <span class="bold">43</span>, 33–56 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S1040-8428(01)00179-2" title="DOI Link to resource 10.1016/S1040-8428(01)00179-2">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=12098606%5Buid%5D" title="PubMed Link to resource 12098606">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/36_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit37">E. B. Dickerson, E. C. Dreaden, X. H. Huang, I. H. El-Sayed, H. H. Chu, S. Pushpanketh, J. F. McDonald and M. A. El-Sayed, <span class="italic">Cancer Lett.</span>, 2008, <span class="bold">269</span>, 57–66 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.canlet.2008.04.026" title="DOI Link to resource 10.1016/j.canlet.2008.04.026">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhtVagt77O" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18541363%5Buid%5D" title="PubMed Link to resource 18541363">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/37_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit38">D. Gaspar, J. M. Freire, T. R. Pacheco, J. T. Barata and M. A. Castanho, <span class="italic">Biochim. Biophys. Acta</span>, 2015, <span class="bold">1853</span>, 308–316 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.bbamcr.2014.11.006" title="DOI Link to resource 10.1016/j.bbamcr.2014.11.006">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCnt7%252FK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25447543%5Buid%5D" title="PubMed Link to resource 25447543">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/38_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit39">H. K. Wayment-Steele, L. E. Johnson, F. Y. Tian, M. C. Dixon, L. Benz and M. S. Johal, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2014, <span class="bold">6</span>, 9093–9099 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXotlWhtLc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/39_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit40">D. H. Kim, M. D. Losego, K. Hanson, L. Alibabaei, K. Lee, T. J. Meyer and G. N. Parsons, <span class="italic">Phys. Chem. Chem. Phys.</span>, 2014, <span class="bold">16</span>, 8615–8622 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4CP01130A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4CP01130A">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/40_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit41">X.-M. Zhu, J. Yuan, K. C.-F. Leung, S.-F. Lee, K. W. Y. Sham, C. H. K. Cheng, D. W. T. Au, G.-J. Teng, A. T. Ahuja and Y.-X. J. Wang, <span class="italic">Nanoscale</span>, 2012, <span class="bold">4</span>, 5744–5754 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2NR30960B&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2NR30960B">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/41_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit42">M. Hurwitz and P. Stauffer, <span class="italic">Semin. Oncol.</span>, 2014, <span class="bold">41</span>, 714–729 <a target="_blank" class="DOILink" href="https://doi.org/10.1053/j.seminoncol.2014.09.014" title="DOI Link to resource 10.1053/j.seminoncol.2014.09.014">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25499632%5Buid%5D" title="PubMed Link to resource 25499632">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/42_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit43">R. D. Issels, <span class="italic">Eur. J. Cancer</span>, 2008, <span class="bold">44</span>, 2546–2554 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejca.2008.07.038" title="DOI Link to resource 10.1016/j.ejca.2008.07.038">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGhu77E" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18789678%5Buid%5D" title="PubMed Link to resource 18789678">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/43_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit44">X.-M. Zhu, H.-Y. Wan, H. L. Jia, L. Liu and J. F. Wang, <span class="italic">Adv. Healthcare Mater.</span>, 2016, <span class="bold">5</span>, 3165–3172 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adhm.201601058" title="DOI Link to resource 10.1002/adhm.201601058">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhvVKgurzP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27860435%5Buid%5D" title="PubMed Link to resource 27860435">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/44_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit45">R. Colombo, A. Salonia, Z. Leib, M. Pavone-Macaluso and D. Engelstein, <span class="italic">BJU Int.</span>, 2011, <span class="bold">107</span>, 912–918 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1464-410X.2010.09654.x" title="DOI Link to resource 10.1111/j.1464-410X.2010.09654.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXmtl2gsrY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21029314%5Buid%5D" title="PubMed Link to resource 21029314">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/45_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit46">M.-C. Chen, Z.-W. Lin and M.-H. Ling, <span class="italic">ACS Nano</span>, 2016, <span class="bold">10</span>, 93–101 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.5b05043" title="DOI Link to resource 10.1021/acsnano.5b05043">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhvFSmt7fI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26592739%5Buid%5D" title="PubMed Link to resource 26592739">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/46_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li><li><span id="cit47">G. H. Lyman, <span class="italic">J. Natl. Compr. Cancer Network</span>, 2009, <span class="bold">7</span>, 99–108 <a target="_blank" class="DOILink" href="https://doi.org/10.6004/jnccn.2009.0009" title="DOI Link to resource 10.6004/jnccn.2009.0009">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c7ra08560e/47_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li></ol>




<hr/><table><tr><td><h3>Footnote</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic supplementary information (ESI) available. See DOI: <a href="http://xlink.rsc.org/?DOI=c7ra08560e" target="_blank" title="Select to resolve DOI: 10.1039/c7ra08560e">10.1039/c7ra08560e</a></span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2017</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>